Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-19

Clinical Trial Update: Corticosteroid Lumbar Epidural Analgesia for Radiculopathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of corticosteroid lumbar epidural analgesia for lumbosacral radicular pain has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • corticosteroid lumbar epidural analgesia

Snippet

Sponsor: Scilex Pharmaceuticals, Inc. | Conditions: Lumbosacral Radicular Pain | Phase 3 | Status: COMPLETED | Results posted: 2022-09-19